Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Janecka

Showing results (81-90 of 179) with videos related to

Pageof 18
Sort By:
Pharmacological Reports : PR|June 11, 2018
Involvement of α-methylene-γ- and δ-lactones in the suppression of multidrug resistance in MCF-7 cellsAngelika Długosz, Katarzyna Gach-Janczak, Jacek Szymański, et al.
Bioorganic & Medicinal Chemistry|March 6, 2016
Synthesis, biological evaluation and structural analysis of novel peripherally active morphiceptin analogsAnna Adamska, Alicja Kluczyk, Maria Camilla Cerlesi, et al.
Journal of Natural Products|November 22, 2021
Synthesis and Cytotoxic Activity of Lepidilines A-D: Comparison with Some 4,5-Diphenyl Analogues and Related Imidazole-2-thionesGrzegorz Mlostoń, Mateusz Kowalczyk, Małgorzata Celeda, et al.
Chemical Biology & Drug Design|August 21, 2009
The influence of opioids on urokinase plasminogen activator on protein and mRNA level in MCF-7 breast cancer cell lineKatarzyna Gach, Janusz Szemraj, Jakub Fichna, et al.
International Journal of Radiation Oncology, Biology, Physics|January 14, 2014
Low-dose hyper-radiosensitivity is not a common effect in normal asynchronous and G2-phase fibroblasts of cancer patientsDorota Słonina, Beata Biesaga, Anna Janecka, et al.
Chemical Biology & Drug Design|October 26, 2006
In vitro characterization of novel peptide inhibitors of endomorphin-degrading enzymes in the rat brainJakub Fichna, Anna Janecka, Laetitia Bailly, et al.
Molecules (Basel, Switzerland)|April 13, 2023
Anticancer Properties of 3-Dietoxyphosphorylfuroquinoline-4,9-dioneJoanna Drogosz-Stachowicz, Katarzyna Gach-Janczak, Marek Mirowski, et al.
Materials (Basel, Switzerland)|February 7, 2020
Seleninic Acid Potassium Salts as Water-Soluble Biocatalysts with Enhanced BioavailabilityMagdalena Obieziurska, Agata J Pacuła, Anna Laskowska, et al.
Chemmedchem|May 16, 2020
Pharmacological Profile and Molecular Modeling of Cyclic Opioid Analogues Incorporating Various Phenylalanine DerivativesAnna Adamska-Bartłomiejczyk, Piotr F J Lipiński, Justyna Piekielna-Ciesielska, et al.
Molecules (Basel, Switzerland)|September 10, 2021
Harnessing the Anti-Nociceptive Potential of NK2 and NK3 Ligands in the Design of New Multifunctional μ/δ-Opioid Agonist-Neurokinin Antagonist PeptidomimeticsCharlène Gadais, Justyna Piekielna-Ciesielska, Jolien De Neve, et al.
Pageof 18

Showing results (81-90 of 179) with videos related to

Sort By:
Pageof 18
Pharmacological Reports : PR|June 11, 2018
Involvement of α-methylene-γ- and δ-lactones in the suppression of multidrug resistance in MCF-7 cellsAngelika Długosz, Katarzyna Gach-Janczak, Jacek Szymański, et al.
Bioorganic & Medicinal Chemistry|March 6, 2016
Synthesis, biological evaluation and structural analysis of novel peripherally active morphiceptin analogsAnna Adamska, Alicja Kluczyk, Maria Camilla Cerlesi, et al.
Journal of Natural Products|November 22, 2021
Synthesis and Cytotoxic Activity of Lepidilines A-D: Comparison with Some 4,5-Diphenyl Analogues and Related Imidazole-2-thionesGrzegorz Mlostoń, Mateusz Kowalczyk, Małgorzata Celeda, et al.
Chemical Biology & Drug Design|August 21, 2009
The influence of opioids on urokinase plasminogen activator on protein and mRNA level in MCF-7 breast cancer cell lineKatarzyna Gach, Janusz Szemraj, Jakub Fichna, et al.
International Journal of Radiation Oncology, Biology, Physics|January 14, 2014
Low-dose hyper-radiosensitivity is not a common effect in normal asynchronous and G2-phase fibroblasts of cancer patientsDorota Słonina, Beata Biesaga, Anna Janecka, et al.
Chemical Biology & Drug Design|October 26, 2006
In vitro characterization of novel peptide inhibitors of endomorphin-degrading enzymes in the rat brainJakub Fichna, Anna Janecka, Laetitia Bailly, et al.
Molecules (Basel, Switzerland)|April 13, 2023
Anticancer Properties of 3-Dietoxyphosphorylfuroquinoline-4,9-dioneJoanna Drogosz-Stachowicz, Katarzyna Gach-Janczak, Marek Mirowski, et al.
Materials (Basel, Switzerland)|February 7, 2020
Seleninic Acid Potassium Salts as Water-Soluble Biocatalysts with Enhanced BioavailabilityMagdalena Obieziurska, Agata J Pacuła, Anna Laskowska, et al.
Chemmedchem|May 16, 2020
Pharmacological Profile and Molecular Modeling of Cyclic Opioid Analogues Incorporating Various Phenylalanine DerivativesAnna Adamska-Bartłomiejczyk, Piotr F J Lipiński, Justyna Piekielna-Ciesielska, et al.
Molecules (Basel, Switzerland)|September 10, 2021
Harnessing the Anti-Nociceptive Potential of NK2 and NK3 Ligands in the Design of New Multifunctional μ/δ-Opioid Agonist-Neurokinin Antagonist PeptidomimeticsCharlène Gadais, Justyna Piekielna-Ciesielska, Jolien De Neve, et al.
Pageof 18